Russia approved a vaccine that has yet to complete clinical trials. The White House announced a deal to manufacture 100 million doses of its vaccine candidate. New Zealand returned to a partial lockdown.
Russia approved a vaccine that has yet to complete clinical trials. The White House announced a deal to manufacture 100 million doses of its vaccine candidate. New Zealand returned to a partial lockdown.